Priority Medical

ALZHEIMER'S

Challenges In Diagnosing Dementia And Alzheimer’s In Diabetic Patients
ALZHEIMER'S

Challenges In Diagnosing Dementia And Alzheimer’s In Diabetic Patients

The Hidden Link Between Diabetes and Cognitive Decline As the global prevalence of diabetes continues to rise, so does the concern about its impact on cognitive function. Diabetic patients are not only at a higher risk of developing cardiovascular diseases, neuropathy, and retinopathy but also face a significant challenge in diagnosing and managing dementia and Alzheimer’s disease..

Change in Alzheimer's Drug Vial Size Could Be Big Money-Saver for Medicare
ALZHEIMER'S

Change in Alzheimer's Drug Vial Size Could Be Big Money-Saver for Medicare

Introduction A recent analysis published in _JAMA Internal Medicine_ has highlighted a significant issue with the distribution of the Alzheimer's medication lecanemab (Leqembi), leading to substan..

Alzheimer’s Drug Offers Hope for Early-Stage Patients
ALZHEIMER'S

Alzheimer’s Drug Offers Hope for Early-Stage Patients

UConn Health is now offering a groundbreaking treatment for individuals with mild signs of dementia due to Alzheimer's disease. This new drug, lecanemab, has shown significant promise in clinical trials by slowing the progression of the disease..

No more articles to show

Subscribe to Our Newsletter

Stay up-to-date with our latest news, articles, and exclusive offers. Join our community and never miss an important update!

Follow Us